NCT06632197

Brief Summary

The objective of this study is to compare the accuracy and correlation of the capnodynamic method for measuring mixed venous oxygen saturation (SvO2) with the standard reference method (pulmonary artery catheter), with the potential for the capnodynamic method to replace the traditional method in selected cases.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2024

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

October 10, 2024

Status Verified

October 1, 2024

Enrollment Period

Same day

First QC Date

October 6, 2024

Last Update Submit

October 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mixed venous oxygen saturation (SvO2)

    measured using the capnodynamic method in comparison with the invasive standard method using co-oximetry with a pulmonary artery catheter (PAC).

    24 hours

Secondary Outcomes (1)

  • Cardiac output

    24 hours

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will be conducted in the ICU of the Hospital Universitario de la Princesa. The study population will include all patients with medical conditions (respiratory or cardiac) who could benefit from the placement of a PAC and/or the monitoring of mixed venous saturation for clinical management and decision-making, or monitoring of central venous saturation if a pulmonary artery catheter is not required.

You may qualify if:

  • Age \> 18 years
  • Not participating in any other interventional study at the time of the study.
  • Patients under controlled mechanical ventilation in passive conditions.
  • Situations where the responsible physician deems that, for the benefit of clinical management and therapeutic decision-making, the patient would benefit from the placement of a pulmonary artery catheter (Swan-Ganz) and/or monitoring of central or mixed venous saturation.
  • Obtaining informed consent.

You may not qualify if:

  • Failure to obtain informed consent.
  • No need for invasive mechanical ventilation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

HypoventilationHeart Failure

Condition Hierarchy (Ancestors)

Respiratory InsufficiencyRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsHeart DiseasesCardiovascular Diseases

Central Study Contacts

Isabel Magana Bru, MD

CONTACT

Fernando Suarez Sipmann, MD, PdH

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD Intesive Care Medicine, Principal Investigator

Study Record Dates

First Submitted

October 6, 2024

First Posted

October 8, 2024

Study Start

December 1, 2024

Primary Completion

December 1, 2024

Study Completion

August 1, 2025

Last Updated

October 10, 2024

Record last verified: 2024-10